Evidence map›Paper›PMID 28607468›Full record

ArticleScientific reports2017

Clostridium difficile flagella induce a pro-inflammatory response in intestinal epithelium of mice in cooperation with toxins.

Jameel Batah, Hussein Kobeissy, Phuong Trang Bui Pham, Cécile Denève-Larrazet, Sarah Kuehne, Anne Collignon, Claire Janoir-Jouveshomme, Jean-Christophe Marvaud, Imad Kansau

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. A programmed reset mechanism primesScience advances · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. A Mouse Model of MildMicroorganisms · 2024
    Article
  10. Article
  11. International journal of molecular sciences · 2024
    Review
  12. Immunization Strategies Against Clostridioides difficile.Advances in experimental medicine and biology · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Microbiology (Reading, England) · 2023
    Review
  18. Frontiers in microbiology · 2023
    Article
  19. International journal of molecular sciences · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Jameel BatahFaculté de Pharmacie, "Unité Bactéries Pathogènes et Santé" (UBaPS), Université Paris-Sud, Université Paris-Saclay, 92296, Châtenay-Malabry Cedex, France.
Hussein KobeissyFaculté de Pharmacie, "Unité Bactéries Pathogènes et Santé" (UBaPS), Université Paris-Sud, Université Paris-Saclay, 92296, Châtenay-Malabry Cedex, France.
Phuong Trang Bui PhamFaculté de Pharmacie, "Unité Bactéries Pathogènes et Santé" (UBaPS), Université Paris-Sud, Université Paris-Saclay, 92296, Châtenay-Malabry Cedex, France.
Cécile Denève-LarrazetFaculté de Pharmacie, "Unité Bactéries Pathogènes et Santé" (UBaPS), Université Paris-Sud, Université Paris-Saclay, 92296, Châtenay-Malabry Cedex, France.
Sarah KuehneSchool of Dentistry, College of Medical and Dental Sciences, The University of Birmingham, Birmingham, B5 7EG, UK.
Anne CollignonFaculté de Pharmacie, "Unité Bactéries Pathogènes et Santé" (UBaPS), Université Paris-Sud, Université Paris-Saclay, 92296, Châtenay-Malabry Cedex, France.
Claire Janoir-JouveshommeFaculté de Pharmacie, "Unité Bactéries Pathogènes et Santé" (UBaPS), Université Paris-Sud, Université Paris-Saclay, 92296, Châtenay-Malabry Cedex, France.
Jean-Christophe MarvaudFaculté de Pharmacie, "Unité Bactéries Pathogènes et Santé" (UBaPS), Université Paris-Sud, Université Paris-Saclay, 92296, Châtenay-Malabry Cedex, France.
Imad KansauFaculté de Pharmacie, "Unité Bactéries Pathogènes et Santé" (UBaPS), Université Paris-Sud, Université Paris-Saclay, 92296, Châtenay-Malabry Cedex, France. imad.kansau@u-psud.fr.
Université Paris-Saclay · FRBirmingham Dental Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clostridium difficile is the most important enteropathogen involved in gut nosocomial post-antibiotic infections. The emergence of hypervirulent strains has contributed to increased mortality and morbidity of CDI. The C. difficile toxins contribute directly to CDI-associated lesions of the gut, but other bacterial factors are needed for the bacteria to adhere and colonize the intestinal epithelium. The C. difficile flagella, which confer motility and chemotaxis for successful intestinal colonization, could play an additional role in bacterial pathogenesis by contributing to the inflammatory response of the host and mucosal injury. Indeed, by activating the TLR5, flagella can elicit activation of the MAPK and NF-κB cascades of cell signaling, leading to the secretion of pro-inflammatory cytokines. In the current study, we demonstrate, by using an animal model of CDI, a synergic effect of flagella and toxins in eliciting an inflammatory mucosal response. In this model, the absence of flagella dramatically decreases the degree of mucosal inflammation in mice and the sole presence of toxins without flagella was not enough to elicit epithelial lesions. These results highlight the important role of C. difficile flagella in eliciting mucosal lesions as long as the toxins exert their action on the epithelium.

Indexed as

FlagellaAnimalsBacterial ToxinsChlorocebus aethiopsClostridioides difficileClostridium InfectionsDisease Models, AnimalFemaleGene Knockout TechniquesInflammationIntestinal MucosaMice, Inbred C57BLMice, KnockoutNF-kappa BSignal TransductionToll-Like Receptor 5Bacterial ToxinsNF-kappa BToll-Like Receptor 5

Identifiers

PMID28607468
PMCPMC5468286
OpenAlexW2622733533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.